Skip to content
Disclosery

EXANE DERIVATIVES: DG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4 DG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4 shares
    Change vs previous 13F -22 shares

    <0.01% of the 13F portfolio, value $982.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 26 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $5,788.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 26 shares
    Change vs previous 13F -5,359 shares

    <0.01% of the 13F portfolio, value $6,132.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5,385 shares
    Change vs previous 13F -2,292 shares

    0.29% of the 13F portfolio, value $1,142,408.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,677 shares
    Change vs previous 13F +165 shares

    0.4% of the 13F portfolio, value $1,689,122.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 7,512 shares
    Change vs previous 13F +102 shares

    0.46% of the 13F portfolio, value $1,522,134.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 7,410 shares
    Change vs previous 13F +4,809 shares

    0.47% of the 13F portfolio, value $1,558,374.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,601 shares
    Change vs previous 13F not available

    0.18% of the 13F portfolio, value $545,227.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).